PharmaEssentia dividend and valuation

6446 · TWSE · TWD

Compare PharmaEssentia
$1,100.00Change from previous close: −8.71%Absolute change: −$105.00

Close · November 20, 2026

Valuation

PharmaEssentia paid $1.49 per share in dividends over the last 12 months (yield 0.1%). Last ex-dividend date: July 9, 2026. The P/E ratio is 74.1. The average price target of 8 analysts is $1,437.27.

Data as of November 22, 2026

PharmaEssentia compared with similar companies

PharmaEssentia's P/E (trailing 12 months): 74.1, +158% against the median of a group of 11 similar companies (28.7).

PharmaEssentia's metrics compared with similar companies
MetricPharmaEssentiaMedian25th–75th percentileBand
P/E (trailing 12 months)74.128.717.9 – 56.8High
Forward P/E29.324.317.9 – 29.1High
EV/EBITDA41.518.313.8 – 28.7High
Price/book14.03.241.91 – 7.00High
Price/sales24.94.102.84 – 11.0High
Gross margin90.9%74.7%61.5% – 79.2%High
Operating margin38.4%22.2%15.1% – 32.7%High
Net margin36.8%16.2%12.2% – 33.1%High
ROE23.3%15.2%11.4% – 20.3%High
Debt/equity0.030.210.03 – 0.41Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$526.33B
Enterprise value
$430.22B
EV/revenue
17.5

Profitability and growth

ROA
12.9%
ROIC
14.8%
Revenue growth (year over year)
90.3%
Earnings growth (year over year)
203.5%

Financial health

Total cash
$26.76B
Total debt
$1.11B
Current ratio
5.28
Quick ratio
4.76
Altman Z-Score
25.5
Piotroski F-Score
7.00

Dividends

Annual dividend per share
$1.49
Dividend yield
0.1%
Payout ratio
6.8%
Ex-dividend date
July 9, 2026

Analysts and estimates

Average price target
$1,437.27
Median price target
$1,517.50
High price target
$2,143.00
Low price target
$500.33
Analysts with a price target
8
Consensus
Buy
EPS estimate, current year
$25.86

Shares and trading

Beta
0.65
Average volume
3.4M
Shares outstanding
414.43M
Float
330.87M
Institutional ownership
23.2%
Insider ownership
8.1%